Skip to main content
. 2011 Sep;49(9):3114–3121. doi: 10.1128/JCM.00469-11

Table 5.

Clinical presentation of Alaska Native and non-Native persons infected with Helicobacter pylori strains with and without the cagA gene and with vacA genotypes s1m1, s1m2, and s2m2 in Alaska from 1998 to 2005

Clinical presentation cagA statusa
vacA genotypeb
No. (%) of patients
P value No. (%) of patients with genotype
P valuec
Positive (n = 222) Negative (n = 38) s1m1 (n = 107) s1m2 (n = 37) s2m2 (n = 98)
Endoscopic evaluation
    Duodenitis 40 (18) 6 (16) 0.74 22 (21) 9 (24) 15 (15) 0.42
    Esophagitis 46 (21) 17 (45) 0.003 15 (14) 11 (30) 35 (36) 0.001d
    Moderate or severe gastritis 96 (43) 19 (50) 0.44 48 (45) 19 (51) 44 (45) 0.77
    All ulcers 20 (9) 3 (8) 0.82 12 (11) 3 (8) 7 (7) 0.58
    Gastric ulcer 16 (7) 2 (5) 0.65 12 (11) 1 (3) 4 (4) 0.07
Medical chart review
    History of gastritis 93 (42) 13 (34) 0.37 46 (43) 11 (30) 43 (44) 0.28
    History of PUD 32 (14) 4 (11) 0.51 21 (20) 4 (11) 9 (9) 0.08
    Ulcer at enrollment or history of PUD 46 (21) 6 (16) 0.47 29 (27) 4 (11) 12 (12) 0.01e
a

Persons with both cagA-positive and cagA-negative H. pylori colonies were considered to be infected with a cagA-positive strain.

b

vacA genotype s2m1 was left out due to the small sample size (n = 1).

c

The P value examines differences in clinical outcomes among the 3 vacA genotypes. Boldface type indicates significance.

d

P value for s1m1 compared to the other 2 genotypes, 0.0003.

e

P value for s1m1 compared to the other 2 genotypes, 0.003.